BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2562587)

  • 1. [Efficacy of multidrug therapy in treatment of paucibacillary leprosy patients--preliminary results].
    Avelleira JC; Marques AB; Viana FR; de Andrade VL
    Hansenol Int; 1989 Dec; 14(2):107-11. PubMed ID: 2562587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
    Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
    Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
    Katoch K; Ramu G; Ramanathan U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
    Katoch K; Ramu G; Ramanathan U
    Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short course treatment of paucibacillary (TT/BT) leprosy cases.
    Girdhar BK; Girdhar A; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(3):491-8. PubMed ID: 3831086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
    Kumar B; Kaur S; Kaur I
    Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed resolution versus treatment failure in paucibacillary leprosy patients under six months fixed duration multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M
    Indian J Lepr; 1997; 69(2):131-42. PubMed ID: 9290964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of multidrug therapy in paucibacillary leprosy.
    Kar PK; Sohi AS
    J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse of paucibacillary leprosy after short course multidrug therapy.
    Pavithran K
    Indian J Lepr; 1988 Apr; 60(2):225-9. PubMed ID: 3192971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
    Kar PK; Jha PK; Panayach JS; Snehi PS
    Indian J Lepr; 1988 Apr; 60(2):235-41. PubMed ID: 3192972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi.
    Boerrigter G; Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):408-17. PubMed ID: 3418206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight years of follow-up of paucibacillary patients treated with short-course regimens.
    Pattyn SR; Groenen G; Bourland J; Grillone G; Kuykens L; Stes P
    Lepr Rev; 1992 Mar; 63(1):80-2. PubMed ID: 1569821
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug therapy for paucibacillary leprosy: WHO regimen inadequate?
    Pavithran K
    Lepr Rev; 1987 Sep; 58(3):306-8. PubMed ID: 3669872
    [No Abstract]   [Full Text] [Related]  

  • 20. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
    Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
    Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.